5d 1m 3m 1y 5y 10y
There are 4 articles on this stock available only to PRO subscribers.
There are no Transcripts on ADXS.
GlobeNewswire (Thu, 7:30AM)
GlobeNewswire (Mar 3, 2014)
GlobeNewswire (Feb 18, 2014)
GlobeNewswire (Feb 12, 2014)
Advaxis Engages SynCo Bio Partners for Manufacturing of ADXS-HPV, Its Lead Cancer Immunotherapy ProgramGlobeNewswire (Feb 11, 2014)
GlobeNewswire (Feb 3, 2014)
Business Wire (Jan 22, 2014)
Business Wire (Jan 21, 2014)
Business Wire (Jan 15, 2014)
Business Wire (Jan 8, 2014)
ADXS vs. ETF Alternatives
Monday, Dec 92013, 12:32 PM
Monday, Dec 92013, 12:32 PM| 1 Comment
- Advaxis (ADXS +11.1%) rises after saying it has entered into a licensing agreement with Global BioPharma for the development and commercialization of ADXS-HPV.
- Global BioPharma was formed "solely to focus on the development and commercialization of ADXS-HPV," ADXS says.
- ADXS will receive "event-based financial milestones, an annual development fee, and annual net sales royalty payments in the high single to double digits."
- Additionally, Global will make an upfront investment in ADXS common stock.
- For more on the deal, see here.
Monday, Dec 92013, 9:15 AM
Monday, Nov 112013, 12:45 PM|Monday, Nov 112013, 12:45 PM| 3 Comments
Monday, Nov 42013, 11:13 AM|Monday, Nov 42013, 11:13 AM| 3 Comments